Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)	Common Stock	Additional Paid-In Capital	Stock Payable	Accumulated Deficit	Noncontrolling Interest	Total
Beginning Balance, Shares at Dec. 31, 2017	23,901,252
Beginning Balance, Amount at Dec. 31, 2017	$ 23,902	$ 16,483,632	$ 324,995	$ (18,868,599)	$ 46,885	$ (1,989,185)
Issuance of common stock for professional services, Shares	50,000
Issuance of common stock for professional services, Amount	$ 50	73,950	1,228,333			1,302,333
Warrants granted		37,137				37,137
Beneficial conversion features		646,126				646,126
Noncontrolling interest of Oak Therapeutics, Inc.					(6,676)	(6,676)
Net loss				(1,901,836)		(1,901,836)
Ending Balance, Shares at Mar. 31, 2018	23,951,252
Ending Balance, Amount at Mar. 31, 2018	$ 23,952	17,240,845	1,553,328	(20,770,435)	40,209	(1,912,101)
Beginning Balance, Shares at Dec. 31, 2017	23,901,252
Beginning Balance, Amount at Dec. 31, 2017	$ 23,902	16,483,632	324,995	(18,868,599)	46,885	(1,989,185)
Net loss						(4,304,164)
Ending Balance, Shares at Jun. 30, 2018	25,021,427
Ending Balance, Amount at Jun. 30, 2018	$ 25,022	18,695,056	923,728	(23,172,762)	32,306	(3,496,650)
Beginning Balance, Shares at Mar. 31, 2018	23,951,252
Beginning Balance, Amount at Mar. 31, 2018	$ 23,952	17,240,845	1,553,328	(20,770,435)	40,209	(1,912,101)
Issuance of common stock for professional services, Shares	1,070,175
Issuance of common stock for professional services, Amount	$ 1,070	1,014,544	(776,600)			239,014
Warrants granted		(21,601)				(21,601)
Noncontrolling interest of Oak Therapeutics, Inc.					(7,903)	(7,903)
Issuance of common stock for cancellation of accounts payable, Amount			50,000			50,000
Fair value of stock options and restricted stock granted		461,268				461,268
Issuance of common stock for purchase of patents			97,000			97,000
Net loss				(2,402,327)		(2,402,327)
Ending Balance, Shares at Jun. 30, 2018	25,021,427
Ending Balance, Amount at Jun. 30, 2018	$ 25,022	18,695,056	923,728	(23,172,762)	32,306	(3,496,650)
Beginning Balance, Shares at Dec. 31, 2018	26,784,019
Beginning Balance, Amount at Dec. 31, 2018	$ 26,785	23,424,737	645,575	(29,269,000)	16,412	(5,155,491)
Issuance of common stock for professional services, Shares	86,744
Issuance of common stock for professional services, Amount	$ 87	165,371	355,952			521,410
Warrants granted		3,035,190				3,035,190
Beneficial conversion features		801,331				801,331
Noncontrolling interest of Oak Therapeutics, Inc.					(6,691)	(6,691)
Issuance of common stock for extension of maturity dates relating to convertible promissory notes, Shares	105,000
Issuance of common stock for extension of maturity dates relating to convertible promissory notes, Amount	$ 105	320,744				320,849
Issuance of common stock for conversion of convertible promissory notes, Shares	2,844,156
Issuance of common stock for conversion of convertible promissory notes, Amount	$ 2,844	8,620,784	938,260			9,561,888
Issuance of common stock from the equity incentive plan, Shares	130,208
Issuance of common stock from the equity incentive plan, Amount	$ 130	(130)
Issuance of common stock for cash, Shares	416,667
Issuance of common stock for cash, Amount	$ 416	499,584				500,000
Issuance of common stock for cancellation of accounts payable, Amount			64,520			64,520
Fair value of stock options and restricted stock granted		230,291				230,291
Net loss				(10,028,168)		(10,028,168)
Ending Balance, Shares at Mar. 31, 2019	30,366,794
Ending Balance, Amount at Mar. 31, 2019	$ 30,367	37,097,902	2,004,307	(39,297,168)	9,721	(154,871)
Beginning Balance, Shares at Dec. 31, 2018	26,784,019
Beginning Balance, Amount at Dec. 31, 2018	$ 26,785	23,424,737	645,575	(29,269,000)	16,412	(5,155,491)
Net loss						(22,675,775)
Ending Balance, Shares at Jun. 30, 2019	36,487,051
Ending Balance, Amount at Jun. 30, 2019	$ 36,488	58,357,584	3,643,225	(51,944,775)		10,092,522
Beginning Balance, Shares at Mar. 31, 2019	30,366,794
Beginning Balance, Amount at Mar. 31, 2019	$ 30,367	37,097,902	2,004,307	(39,297,168)	9,721	(154,871)
Issuance of common stock for professional services, Shares	186,249
Issuance of common stock for professional services, Amount	$ 187	502,323	(166,562)			335,948
Warrants granted		816,646				816,646
Noncontrolling interest of Oak Therapeutics, Inc.					(9,721)	(9,721)
Issuance of common stock for cash, Shares	208,333
Issuance of common stock for cash, Amount	$ 208	249,792	1,745,000			1,995,000
Fair value of stock options and restricted stock granted		658,647				658,647
Issuance of common stock from exercise of warrants, Shares	25,675
Issuance of common stock from exercise of warrants, Amount	$ 26	(26)	60,480			60,480
Issuance of common stock for acquistion of Chemistry Holdings, Inc, Shares	5,700,000
Issuance of common stock for acquistion of Chemistry Holdings, Inc, Amount	$ 5,700	19,032,300				19,038,000
Net loss				(12,647,607)		(12,647,607)
Ending Balance, Shares at Jun. 30, 2019	36,487,051
Ending Balance, Amount at Jun. 30, 2019	$ 36,488	$ 58,357,584	$ 3,643,225	$ (51,944,775)		$ 10,092,522